- Joined
- Jan 3, 2009
- Messages
- 2,605
- Points
- 0
Non Clonable ID
Finally a tool to beat the curse of counterfeit products
New Delhi: 20 July 2010
NEW DELHI: Bilcare Technologies, a research and technology firm focused on creating next-generation anti-counterfeiting, security and brand protection solutions, announced successful execution of its nonClonableID solution for the security, pharma and agrochemical sectors with the symbolic hand over of technology embedded products to companies like Ranbaxy, Panacea Biotec, Mankind and Indofil on Monday.
The nonClonableID is a unique fingerprint that can be integrated with products, ID cards and documents to provide a totally secure and reliable identification and authentication solution.
Atul Mehrotra of Bilcare said: “NonClonableID employs unique materials-based fingerprints that are prohibitively difficult to copy. These tamper-evident fingerprints are irreproducible and cannot be duplicated even by Bilcare.”
The technology will help in anti-counterfeiting, security and brand protection across a wide array of industry sectors.
Most existing anti-counterfeiting technologies have limitations. Being generic in nature, the counterfeiters are able to figure them out within 9-12 months after deployment of these technologies by the brand owners.
But Bilcare claims that its nonClonableID nanotech fingerprints are not possible to be copied as even Bilcare cannot duplicate them.
The technology enables product authentication on a real-time, anytime-anywhere basis along with complete securitization of the supply chain is making it applicable across diverse sectors viz. pharmaceuticals, agrochemicals, automotive, financial and document securitization, fashion and art segments, aviation.
Even currency notes, certificates and other security documents can be totally protected with this ID system that uses a portable scanner at the consumer end to verify and authenticate.
The product has attracted attention from major American and European companies eager to protect their products and consumers from copy cat counterfeit knock offs.
Worldwide, counterfeit market is estimated around $500 billion, which adversely affects the global economy.
.
Finally a tool to beat the curse of counterfeit products
New Delhi: 20 July 2010
NEW DELHI: Bilcare Technologies, a research and technology firm focused on creating next-generation anti-counterfeiting, security and brand protection solutions, announced successful execution of its nonClonableID solution for the security, pharma and agrochemical sectors with the symbolic hand over of technology embedded products to companies like Ranbaxy, Panacea Biotec, Mankind and Indofil on Monday.
The nonClonableID is a unique fingerprint that can be integrated with products, ID cards and documents to provide a totally secure and reliable identification and authentication solution.
Atul Mehrotra of Bilcare said: “NonClonableID employs unique materials-based fingerprints that are prohibitively difficult to copy. These tamper-evident fingerprints are irreproducible and cannot be duplicated even by Bilcare.”
The technology will help in anti-counterfeiting, security and brand protection across a wide array of industry sectors.
Most existing anti-counterfeiting technologies have limitations. Being generic in nature, the counterfeiters are able to figure them out within 9-12 months after deployment of these technologies by the brand owners.
But Bilcare claims that its nonClonableID nanotech fingerprints are not possible to be copied as even Bilcare cannot duplicate them.
The technology enables product authentication on a real-time, anytime-anywhere basis along with complete securitization of the supply chain is making it applicable across diverse sectors viz. pharmaceuticals, agrochemicals, automotive, financial and document securitization, fashion and art segments, aviation.
Even currency notes, certificates and other security documents can be totally protected with this ID system that uses a portable scanner at the consumer end to verify and authenticate.
The product has attracted attention from major American and European companies eager to protect their products and consumers from copy cat counterfeit knock offs.
Worldwide, counterfeit market is estimated around $500 billion, which adversely affects the global economy.
.
